ORGANIC
LETTERS
2011
Vol. 13, No. 5
1024–1027
Tandem Reaction of Propargylic Alcohol,
Sulfonamide, and N-Iodosuccinimide:
Synthesis of N-(2-Iodoinden-1-yl)-
arenesulfonamide
Yuanxun Zhu, Guangwei Yin, Deng Hong, Ping Lu,* and Yanguang Wang*
Department of Chemistry, Zhejiang University, Hangzhou 310027, P. R. China
pinglu@zju.edu.cn; orgwyg@zju.edu.cn
Received December 20, 2010
ABSTRACT
An efficient and straightforward strategy for the synthesis of N-(2-haloinden-1-yl)arenesulfonamides from propargylic alcohols and sulfonamides
is described. Allenesulfonamide is postulated to be the key intermediate for this tandem transformation.
Indenamine and indene moieties are key substructures in
both targets and building blocks for various biologically
activemolecules1 and functional materials.2 Consequently,
much attention has been paid to the synthesis of indene
derivatives,3 while synthesis of indenamines has been sel-
dom reported. In a few examples in recent literature, in-
denamine derivatives could be synthesized by intramolecular
Friedel-Crafts cyclization of β-aminoaldehyde,4 by car-
bocyclization of o-indobenzaldimine and alkyne,5 and by
annulation of N-unsubstituted aromatic ketimine and
internal alkyne.6 Herein, we report a new convenient
method for the synthesis of N-(2-haloinden-1-yl)arenesul-
fonamide from the corresponding propargylic alcohol,
sulfonamide, and NXS (X = I or Br), which was catalyzed
by BF3 Et2O.
3
In our ongoing efforts to construct the functionalized
indenes, we tested the readily available 4-methylbenzene-
sulfonamide (TsNH2) as the starting material instead of
aziridine, which we previously used.7 By screening various
Lewis acids for the reaction between 1a and 2a, such as
(1) (a) Ahn, J. H.; Shin, M. S.; Jung, S. H.; Kim, J. A.; Kim, H. M.;
Kim, S. H.; Kang, S. K.; Kim, K. R.; Rhee, S. D.; Park, S. D.; Lee, J. M.;
Lee, J. H.; Cheon, H. G.; Kim, S. S. Bioorg. Med. Chem. Lett. 2007, 17,
5239. (b) Kim, K. R.; Lee, J. H.; Kim, S. J.; Rhee, S. D.; Jung, W. H.;
Yang, S.-D.; Kim, S. S.; Ahn, J. H.; Cheon, H. G. Biochem. Pharmacol.
2006, 72, 446. (c) Di Stefano, A.; Sozio, P.; Cacciatore, I.; Cocco, A.;
Giorgioni, G.; Costa, B.; Montali, M.; Lucacchini, A.; Martini, C.;
Spoto, G.; Di Pietrantonio, F.; Di Matteo, E.; Pinnen, F. J. Med. Chem.
2005, 48, 2646. (d) Yu, H.; Kim, I. J.; Folk, J. E.; Tian, X.; Rothman,
R. B.; Baumann, M. H.; Dersch, C. M.; Flippen-Anderson, J. L.;
Parrish, D.; Jacobson, A. E.; Rice, K. C. J. Med. Chem. 2004, 47, 2624.
Yb(OTf)3,AgOTf,Sc(OTf)3,BF3 Et2O, and iodine chloride
3
(4) Katritzky, A. R.; Denisko, O. V.; Busont, S. J. Org. Chem. 2000,
65, 8066.
ꢀ
(2) (a) Barbera, J.; Rakitin, O. A.; Ros, M. B.; Torroba, T. Angew.
(5) Liu, C.-C.; Korivi, R. P.; Cheng, C.-H. Eur. J. Chem. 2008, 14,
9503.
(6) Sun, Z.-M.; Chen, S.-P.; Zhao, P. Eur. J. Chem. 2010, 16, 2619.
(7) Wang, S. Y.; Zhu, Y. X.; Wang, Y. G.; Lu, P. Org. Lett. 2009, 11,
2615.
Chem., Int. Ed. 1998, 37, 296. (b) Yang, J.; Lakshmikantham, M. V.;
Cava, M. P.; Lorcy, D.; Bethelot, J. R. J. Org. Chem. 2000, 65, 6739.
(3) (a) Chatterjee, P. N.; Roy, S. J. Org. Chem. 2010, 75, 4413. (b) Liu,
C.-R.; Yang, F.-L.; Jin, Y.-Z.; Ma, X.-T.; Cheng, D.-J.; Li, N.; Tian,
S.-K. Org. Lett. 2010, 12, 3832.
r
10.1021/ol103074d
Published on Web 01/26/2011
2011 American Chemical Society